Abstract |
The use of musculoskeletal ultrasonography (MSUS) in guiding subdeltoid injection has been shown to improve outcome up to 6 weeks in a few small studies. A recent meta-analysis identified the need for further studies with longer-term outcome and larger sample size. This randomized prospective study assessed whether clinic-based MSUS can significantly improve diagnostic accuracy in shoulder pain and whether MSUS-guided shoulder injection results in improved long-term outcomes. One hundred consecutive patients with 125 painful shoulders were recruited. Patients were randomized to receive either sonographic assessment with consequent palpation-guided injection (Group 1, n = 66) or sonographic assessment with a MSUS-guided injection of 40 mg of methylprednisolone acetate (Group 2, n = 59). A blinded rheumatologist (ADF) performed clinical assessments at baseline, 6 and 12 weeks including shoulder function tests (SFTs) (Hawkins-Kennedy test, supraspinatus tendon tenderness), physician global assessment ( PGA) and patient visual analogue scores (VAS) for pain (0-10). Eighty patients with 90 symptomatic shoulders completed 12-week follow-up. Twenty patients, 11 (20 shoulders) from the palpation-guided group and 9 (15 shoulders) from the MSUS-guided group, were excluded at 6 weeks either due to requirement for repeat injection or due to surgical referral. Mean age for patients was 57.7 years, and 65 % patients were female; mean shoulder pain duration was 18 weeks (range 14-22 weeks). SFTs, patient VAS and PGA scores for pain improved significantly from baseline in both groups with significantly greater improvements in the MSUS-guided group (44 shoulders) compared to the palpation-guided group (46 shoulders) in all parameters at 6 (p < 0.01) and 12 weeks (p < 0.05). The use of MSUS in guiding subdeltoid injection has been shown to improve outcome up to 6 weeks in a few small studies. A recent meta-analysis identified the need for further studies with longer-term outcome and larger sample size.
|
Authors | Aamir Saeed, Mumtaz Khan, Siobhan Morrissey, David Kane, Alexander Duncan Fraser |
Journal | Rheumatology international
(Rheumatol Int)
Vol. 34
Issue 4
Pg. 503-9
(Apr 2014)
ISSN: 1437-160X [Electronic] Germany |
PMID | 24190232
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Anti-Inflammatory Agents
- Glucocorticoids
- Methylprednisolone Acetate
- Methylprednisolone
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Ambulatory Care
- Anti-Inflammatory Agents
(administration & dosage)
- Biomechanical Phenomena
- Female
- Glucocorticoids
(administration & dosage)
- Humans
- Injections, Intra-Articular
- Ireland
- Male
- Methylprednisolone
(administration & dosage, analogs & derivatives)
- Methylprednisolone Acetate
- Middle Aged
- Pain Measurement
- Predictive Value of Tests
- Prospective Studies
- Recovery of Function
- Shoulder
(diagnostic imaging, physiopathology)
- Shoulder Impingement Syndrome
(diagnostic imaging, drug therapy, physiopathology)
- Shoulder Pain
(diagnostic imaging, drug therapy, physiopathology)
- Single-Blind Method
- Time Factors
- Treatment Outcome
- Ultrasonography
- Young Adult
|